Sirolimus-induced aphthous ulcers which disappeared with conversion to everolimus.
Ram
Rapur
R
Swarnalatha
Gudithi
G
Neela
Prasad
P
Dakshinamurty
Kaligotla Venkata
KV
D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D019226:Oral Ulcer / Q000139:chemically induced* / Q000473:pathology; D020123:Sirolimus / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013281:Stomatitis, Aphthous; D014060:Tongue Diseases / Q000139:chemically induced* / Q000473:pathology
D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus